openPR Logo
Press release

Predictive Genetic Testing and Consumer/Wellness Genomics Market Outlook to 2025 Update 2017

08-18-2017 12:27 PM CET | Health & Medicine

Press release from: TMR Research

Predictive Genetic Testing and Consumer/Wellness Genomics

Predictive Genetic Testing and Consumer/Wellness Genomics Market

Over centauries human DNA has undergone tremendous alteration due to evolutionary and lifestyle changes. They have led to both, advantages and disadvantages over the years. Some have given the mankind a deserving edge over other creatures while the others have led to disorders and diseases. Predictive genetic testing and consumer/wellness genomics market thrives on the growing demand for understanding the lineage of a certain gene pool to identify disorders that could manifest in the later or early stage of a human life. The surging demand for understanding the family history or studying the nature of certain diseases has given the global market for predictive genetic testing and consumer/wellness genomics market adequate fodder for growth in the past few years.

This new class of medical tests are aimed at reducing the risk of morbidity and mortality amongst consumers. The thorough surveillance and screening of a certain gene pool can allow an individual to avoid conditions that disrupt normal existence through preventive measures. The clinical utility of these tests remains unassessed. Therefore, increasing research and development by pharmaceutical companies to develop new drugs by understanding diseases and disorders is expected to favor market growth.

Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1274

Unlike conventional diagnostic testing, predictive genetic testing identifies the risk associated with potential conditions. In certain cases it is also capable of stating when the disease may appear and the how severe will it be. Thus, this form of testing is expected to allow consumers to take up wellness measurements well in time to lead a life of normalcy, characterized by good health.

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Overview

Predictive genetic testing are used to identify gene mutations pertaining to the disorders that surface at a considerably later stage in life after birth. These tests are particularly beneficial for people from a family with a history of genetic disorder, although they themselves show no symptoms of the disorder at the time of testing. Genetic testing promises to revolutionize the healthcare sector, providing crucial diagnostic details related to diverse verticals such as heart disease, autism, and cancer. As the healthcare sector touches new peaks, the global predictive genetic testing and consumer/wellness genomics market is projected to expand at a healthy growth rate during the forecast period of 2017 to 2025.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1274

This report on the global market for predictive genetic testing and consumer/wellness genomics analyzes all the important factors that may influence the demand in the near future and forecasts the condition of the market until 2025. It has been created using proven research methodologies such as SWOT analysis and Porter’s five forces. One of the key aspect of the report is the section on company profiles, wherein several leading players have been estimated for their market share and analyzed for their geographical presence, product portfolio, and recent strategic developments such as mergers, acquisitions, and collaborations.

The global predictive genetic testing and consumer/wellness genomics market, on the basis of test type, can be segmented into predictive testing, consumer genomics, and wellness genetics. The segment of predictive testing can be sub-segmented into genetic susceptibility test, predictive diagnostics, and population screening programs, whereas the segment of wellness genetics can be further divided into nutria genetics, skin and metabolism genetics, and others. By application, the market can be segmented into breast and ovarian cancer screening, cardiovascular screening, diabetic screening and monitoring, colon cancer screening, Parkinson’s or Alzheimer’s disease, urologic screening or prostate cancer screening, orthopedic and musculoskeletal screening, and other cancer screening. Geographically, the report studies the opportunities available in regions such as Asia Pacific, Europe, North America, and the Middle East and Africa.

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Trends and Opportunities

Increasing number of novel partnership models, rapidly decreasing cost of genetic sequencing, and introduction of fragmented point-solutions across the genomics value chain as well as technological advancements in cloud computing and data integration are some of the key factors driving the market. On the other hand, the absence of well-defined regulatory framework, low adoption rate, and ethical concerns regarding the implementation, are expected to hinder the growth rate during the forecast period. Each of these factors have been analyzed in the report and their respective impacts have been anticipated.

Get a discount @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=1274

Currently, the segment of predictive genetic cardiovascular screening accounts for the maximum demand, and increased investments in the field is expected to maintain it as most lucrative segment. On the other hand, more than 70 companies are currently engaged in nutrigenomics, which is expected to further expand the market.

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Regional Outlook

Owing to robust healthcare infrastructure, prevalence of cardiovascular diseases, and high adoptability rate of new technology makes North America the most lucrative region, with most of the demand coming from the country of the U.S. and Canada. Several U.S. companies hold patents, which further extends the outreach of the market in the region of North America.

Companies mentioned in the research report

23andMe, Inc, BGI, Genesis Genetics, Illumina, Inc, Myriad Genetics, Inc, Pathway Genomics, Color Genomics Inc., and ARUP Laboratories are some of the key companies currently operating in global predictive genetic testing and consumer/wellness genomics market. Various forms of strategic partnerships with operating company and smaller vendors with novel ideas helps these leading players maintain their position in the market.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth researh of the market, we try to bring about game-changing success for our clients.

Contact :

Rohit Bhisey
Head - Internet Marketing
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Predictive Genetic Testing and Consumer/Wellness Genomics Market Outlook to 2025 Update 2017 here

News-ID: 674388 • Views: 132

More Releases from TMR Research

Configuration Management Market 2018-2028 | CA Technologies, BMC Software, Oracl …
Global Configuration Management Market: Overview The demand within the global configuration management market is rising on account of advancements in the domain of product analysis and optimization. Development of a product or system is followed by a rigorous process of optimization to increase the efficiency and life of the system. The need to retain the utility and effectiveness of products has created tremendous demand within the global configuration management market. The
Security Orchestration Automation and Response Market | Qualitative Opportunitie …
Global Security Orchestration Automation and Response Market: Overview The demand within the global security orchestration automation and response is growing on account of advancements in the field of organizational security. The need to protect data and key assets across companies and organizations has played an integral role in the growth of the global security orchestration automation and response market. Furthermore, the growing level of automation across industrial and commercial units has
Global AI in Fashion Market Overview, Development, Segment by Type, Application …
AI in Fashion Market: Overview The global market for AI in fashion is expected to witness a stellar growth in coming few years. The market is expected flourish due to emergence of several fashion trends all across the globe. Fashion across the globe keeps on changing at a moment’s notice. It has become incredibly hard to keep a solid track of all the important fashion related activities. This has been a
Crowdsourced Security Market 2018 - 2028 | TMR Research
Crowdsourced Security Market: Overview The global crowdsourced security market is expected develop at a healthy pace in the coming years of the forecast period of 2018 to 2028. The mobile phone application segment of the crowdsourced security market is expected to develop at a rapid pace in these coming years. The rate of adoption of these mobile application is growing at a great pace and is thus helping the market to

All 5 Releases


More Releases for Genetic

Preimplantation Genetic Diagnosis: Scope & Revenue Outlook
Rising numbers of assisted reproductive procedures such as in vitro fertilization (IVF) is Asia is the most prominent factor driving the market for preimplantation genetic diagnosis. This is, in essence, the result of factors such as the delayed age of conception among Asian women, the rising rate of infertility among the population, and the significantly expanding medical tourism industry in the region. Rising disposable incomes and increased awareness regarding the
Preimplantation Genetic Testing Market-Size Report 2022
Preimplantation Genetic Testing Market by type 2017-2022 by new Service spreads across 204 pages profiling 17 companies and supported with 85 tables and 42 figures available at ReportsnReports.com Get sample copy for information professional insights@ http://www.reportsnreports.com/contacts/requestsample.aspx?name=1128201 “Preimplantation Genetic Testing Market projected to grow at a CAGR of 10.0%” The global preimplantation genetic testing market is expected to reach USD 541.8 million by 2022 from USD 336.4million in 2017, at a CAGR
India Genetic Testing Market Analysis
India is witnessing an accelerating shift towards the prevalence of non-communicable diseases, having secured third position in congenital malformations and genetic disorders as the commonest causes of mortality in neonates in cities. The ability to identify these non-communicable diseases at an early stage lies within the genetic screening segment. Genetic screening, however, is still in its infancy and there are many challenges that need to be overcome in order to
RBD Creative partners with Reproductive Genetic Innovations
Acknowledged in D Business' Faces of Detroit in 2015, RBD Creative, a local Plymouth marketing and design studio, is proud to announce a new partnership with Reproductive Genetic Innovations (RGI) of Northbrook, IL. RBD Creative specializes in health and wellness marketing solutions and has several notable clients including: University of Michigan Health System, University of Michigan School of Medicine, Lakes Urgent Care, Evangelical Homes of Michigan, Cryowellness USA, Michigan Reproductive
Preimplantation Genetic Diagnosis - Saving Offsprings From Any Genetic Disorder
The market for preimplantation genetic diagnosis (PGD) in Asia features high fragmentation when it comes to diagnostic service providers. The large number of local players has intensified the competitive rivalry in the region. However, owing to the lack of better alternatives to PGD, costs of these procedures remain high, a major limiting factor for the market, especially in cost-sensitive developing countries in the region. A recent report by TMR suggests that
OGT aids research into molecular genetic disease
Unique CytoSure™ Molecular Testing Arrays provide high throughput CNV detection for multiple disorders on a single chip Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced a new range of CytoSure™ Molecular Testing Arrays and Panels. The new DNA microarrays utilise a unique collection of probes for detecting copy number variations (CNVs) within genes associated with a variety of disorders. Three